1-Phenylpiperazine → L-Isoleucine
Reaction equation
C(CN1CCC[C@H]1C(N(CC1C=CC=CC=1)[C:10](=[O:17])[C@H:11]([C@H:13]([CH2:15][CH3:16])[CH3:14])[NH2:12])=O)(O)=O.C(N(CC)CC)C.ClC(OCC(C)C)=[O:37].C1(N2CCNCC2)C=CC=CC=1>C(#N)C>[NH2:12][C@H:11]([C:10]([OH:17])=[O:37])[C@H:13]([CH2:15][CH3:16])[CH3:14]Participants
6
Procedure
A -5° C. solution of L-isoleucine, N-[1-(carboxymethyl)-L-prolyl] benzylamide (0.214 g, 0.58 mmol, 1.0 eq), and triethylamine (96 uL, 70 mg, 0.64 mol, 1.20 eq), in acetonitrile (6 mL) was treated with isobutyl chloroformate (83 uL, 86 mg, 0.63 mmol, 1.1 eq) followed by 4-phenylpiperazine (170 uL, 186 mg, 1.15 mmol, 2.0 eq). Workup as above provided 170 mg (57%) of L-isoleucine, N-[1-[2-(4-phenylpiperazine)-2-oxoethyl]-L-prolyl] benzylamide.
Sources & evidence
- ORD record
- ord-2129e019e0b847fbaa45d1ddf8677a75
- Source dataset
- uspto-grants-1997_11
- Patent number
- US05686424
Reaction notes
Loading…